Connect with us

Technology

New ARUP Laboratories’ Grant Will Fund Innovative Research to Advance Laboratory Medicine

Published

on

SALT LAKE CITY, July 30, 2024 /PRNewswire/ — The ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute) today announced the creation of the Sherrie Perkins Research and Innovation Collaboration Grant. The new grant will fund cutting-edge research in laboratory medicine that has the potential to significantly impact patient care.

The grant is designed to foster partnerships within the medical community and may award up to a maximum of $150,000. The grant will be available to industry and academic partners in collaboration with ARUP medical directors and scientists.

“With this grant program, ARUP will fund innovation efforts that focus on improving laboratory medicine while also establishing partnerships with academic or industry collaborators,” said Tracy George, MD. George, ARUP’s chief scientific officer and president of the Innovation Business Unit, has been a key proponent of innovation at ARUP.

The grant is named in honor of retired ARUP CEO Sherrie Perkins, MD, PhD, who held many key leadership roles throughout her career at ARUP. In addition to serving as CEO until mid-2021, she was chief medical officer, senior vice president for research, and section chief of Hematopathology. Perkins laid the groundwork for an increased focus on innovation at ARUP while serving as a driving force behind Clinical Trials, PharmaDx, and the ARUP Institute for Clinical and Experimental Pathology®, which she codirected.

“Perkins initiated early innovation programs and recognized that ARUP needed to be a leader in research in laboratory medicine. We recognize her leadership in innovation by naming this research grant in her honor,” George said.

“This is a great honor,” Perkins said. “What ARUP does well is in innovation, discovery, and improvement. This grant reflects ARUP’s dedication to innovation and a reenergization of ARUP’s core academic mission to drive innovation in laboratory medicine.”

The grant is the latest development from ARUP’s R&I Institute, which was founded in September 2023 with a core mission to improve the lives of patients by advancing groundbreaking diagnostic and prognostic technologies and innovative tests.

“We want to be sure that we stay true to the mission of R&I—to drive true innovation and cutting-edge research that looks years into the future,” said Robert Ohgami, MD, PhD, FCAP, vice president of the R&I Institute. “This grant will provide the resources to foster research that may not otherwise be supported.”

Leo Lin, MD, PhD, an ARUP medical director of Immunology, PharmaDx, and the R&I Institute, played a key role in the development of this grant.

“We hope to kickstart collaborations between ARUP Laboratories and other industry and academic partners, especially smaller companies that may not have as many resources,” Lin said.

This grant will join the slate of funding opportunities ARUP already provides to medical directors and scientists to advance laboratory medicine.

“ARUP offers a variety of funding opportunities to medical directors and scientists, from the William Roberts fund focused on trainees and medical directors early in their careers to larger funding opportunities such as the Sherrie Perkins Research grant. These research grants reflect the pillars that define ARUP,” George said.

To learn more about the R&I Institute and to inquire about the grant, please visit aruplab.com/arup-institute-for-research-and-innovation.

About ARUP Laboratories

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation’s top university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™. ARUP is ISO 15189 CAP accredited.

ARUP Media Contact:

Bonnie Stray, bonnie.stray@aruplab.com, 801-583-2787 ext. 2823

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-arup-laboratories-grant-will-fund-innovative-research-to-advance-laboratory-medicine-302210232.html

SOURCE ARUP Laboratories

Continue Reading

Technology

Rho Launches Card Payments on Invoices, Letting Businesses Accept Credit Card, Debit Card, and Google Pay

Published

on

By

Rho Invoicing customers can now accept credit card payments on invoices alongside ACH and wire, from the same account they already use for banking, with invoices syncing automatically to QuickBooks Online

NEW YORK, Sept. 4, 2026 /PRNewswire/ — Rho, the all-in-one finance platform for businesses, today announced that Rho Invoicing customers can now accept credit and debit card payments, including Google Pay, directly on their invoices. The feature is rolling out to eligible Rho Invoicing customers and adds to the existing ACH, domestic wire, and international wire options already available on Rho invoices. No separate merchant account, no new dashboard, and no waiting on a wire.

Here is how it works for the payer: your client opens the invoice, enters their card information, and pays in a few clicks. Card payments carry a processing fee of 2.9% plus $0.30 per transaction, paid by the business issuing the invoice and deducted from the payment before depositing into your account. Inbound ACH and wire stay free, and the payer never sees a surcharge at checkout. Card payments cover USD-denominated invoices and have a default daily limit of $10,000 across all of a business’s invoices, which can be raised on request.

An invoice is marked paid once the payout is initiated, and funds follow on card-network timelines rather than instantly. A business’s first card payment can take up to two weeks to deposit while Stripe, which powers Rho’s card payment features, completes its initial review.

Rho Invoicing remains free for all Rho customers, aside from card processing fees, and supports up to 100 line items per invoice with per-line sales tax, recurring billing, payment matching, and a fully white-labeled template that carries the business’s brand rather than Rho’s, with virtual account numbers that keep the business’s actual bank details private. Rho invoices sync into QuickBooks Online as accounts receivable through Rho’s direct integration, so AR aging stays accurate without duplicate entry.

Card payments run through the same Rho account a business already uses for banking, corporate cards, and bill pay. No merchant account. No second dashboard. No new password to add to a growing list. Getting paid should not add another tool to the financial stack.

Availability is limited to eligible Rho Invoicing customers for USD-denominated invoices. Access to and enablement of card payment functionality requires completion of Stripe’s verification process and is subject to third-party underwriting and approval, which is not guaranteed.

To learn more, read how to accept credit card payments with Rho Invoicing.

About Rho

Rho is the modern banking platform built for the AI era. Startups and growth-stage companies can open accounts in minutes, issue cards, manage expenses, pay bills, and close the books – all in one connected platform backed by real human support.

Rho is a fintech company, not a bank or an FDIC-insured depository institution. Checking account and card services provided by Webster Bank, a division of Santander Bank, N.A. Member FDIC.

Card payment features on Rho Invoicing, including credit card, debit card, and Google Pay options, are powered by Stripe, Inc. This content is for informational purposes only. It doesn’t necessarily reflect the views of Rho and should not be construed as legal, tax, benefits, financial, accounting, or other advice. If you need specific advice for your business, please consult with an expert, as rules and regulations change regularly.

Media Contact:
Justin Wolz
justin.wolz@rho.co
(919) 306-7084

View original content:https://www.prnewswire.com/news-releases/rho-launches-card-payments-on-invoices-letting-businesses-accept-credit-card-debit-card-and-google-pay-302870490.html

SOURCE Rho

Continue Reading

Technology

Amwell Receives Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms

Published

on

By

Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve access, efficiency, and outcomes.

SAN ANTONIO, Sept. 4, 2026 /CNW/ — As healthcare organizations move beyond fragmented telehealth solutions toward connected virtual care models, Amwell is helping redefine how digital care is delivered at scale. Frost & Sullivan is pleased to recognize Amwell with the 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms industry for its ability to address healthcare fragmentation through a unified platform that connects patients, health plan members, clinicians, and partner ecosystems across the care continuum.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Amwell excelled in both, demonstrating its ability to align strategic initiatives with evolving healthcare needs while executing with flexibility, scalability, and measurable customer impact. “The combination of reliability, flexibility, and clinically integrated workflows positions the Amwell Platform as a strategic enabler for organizations seeking to reduce fragmentation, improve member engagement with covered programs, expand access to care, and create more connected healthcare experiences,” said Sagar Mukhekar, Industry Analyst, Frost & Sullivan.

Guided by a strategy centered on connected care, interoperability, and continuous, digital innovation, Amwell has positioned the Amwell Platform as an operating layer for next-generation healthcare delivery. Rather than relying on disconnected point solutions, the platform integrates technology, services, and clinical intelligence to orchestrate personalized care experiences across virtual primary care, urgent care, behavioral health, chronic condition management, and specialized digital programs.

Backed by 20 years of technology-enabled care innovation, more than 90 million covered lives, and over 38.7 million virtual visits, Amwell continues to help health plans and healthcare organizations modernize digital care delivery at scale.

“As healthcare becomes more digital, it risks becoming more fragmented. Health plans need more than point solutions. They need enterprise infrastructure, clinical integration, and an open platform that brings partners and programs together. Our vision at Amwell is that technology creates value when it improves access, engagement, quality, and efficiency, and produces measurable clinical and business outcomes. We’re honored by this recognition from Frost & Sullivan,” said Dan Zamansky, Chief Product and Technology Officer at Amwell.

Amwell’s enterprise scale includes supporting the digital transformation of the Defense Health Agency’s Military Health System, serving approximately 9.6 million beneficiaries. The company’s commitment to measurable outcomes is also reflected in a landmark National Institute of Mental Health (NIMH)-funded study, published in Nature Human Behaviour and among the largest studies of its kind. The study found that students offered SilverCloud® by Amwell® engaged in mental healthcare at more than double the rate of traditional care, experienced lower rates of mental health disorders, and generated an estimated $1.18 million in avoided costs for the study population.

The company further differentiates its platform through intelligent orchestration and navigation, helping guide members to appropriate programs while giving clinicians visibility across care plans. Amwell also evaluates integrated third-party programs for clinical effectiveness, scalability, and enterprise readiness.

Frost & Sullivan commends Amwell for setting a high standard in competitive strategy, execution, and technological innovation. The company’s unified approach to digital care is helping reduce fragmentation, improve access, strengthen operational efficiency, and support more equitable and sustainable healthcare delivery.

Each year, Frost & Sullivan presents the Technology Innovation Leadership Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The recognition identifies forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Ashley Shreve
E: ashley.weinkauf@frost.com 

View original content:https://www.prnewswire.com/news-releases/amwell-receives-frost–sullivans-2026-united-states-technology-innovation-leadership-recognition-for-technology-enabled-care-platforms-302870492.html

SOURCE Frost & Sullivan

Continue Reading

Technology

Midea Brings “Simply ideal” to Life at IFA 2026

Published

on

By

BERLIN, Sept. 4, 2026 /PRNewswire/ — At IFA 2026, Midea brings its “Simply ideal” vision to life through the latest innovations, designed to bring greater intelligence, comfort, efficiency and ease to the home.

The exhibition also highlights Midea’s new five-year partnership with FC Barcelona.

The Midea Suites: Ways to Master the Home

The new SMART MASTER showcases Midea’s AI-powered home ecosystem. The AI Agent enables more natural, intuitive interaction with appliances across daily household scenarios. Midea Robot brings AI into the physical world through cooking, cleaning, laundry, care and whole-home control.

At IFA 2026, Midea unveiled its new AI voice-controlled air conditioner. Cliff Liang, General Manager of Enterprise Commercial for the China Region at Microsoft, joined the Midea event and shared Microsoft’s perspective on the next phase of AI.

AI ECOMASTER coordinates appliances and connected systems through intelligent power management. It learns household routines and adapts to changing needs for greater flexibility and comfort.

For homes where every inch counts, SPACE MASTER delivers more usable capacity within the same external dimensions, as demonstrated by the refrigerator’s expanded storage.

Alongside the MASTER Suites, the BUILT-IN Series includes the Milanese-inspired Ispira Series, combining cohesive design with intelligent functionality for an integrated cooking experience.

The Midea Scenarios: Innovation for Everyday Living

Comfort begins with the air around us. Midea’s R290 Series responds to growing demand for efficient cooling. It combines advanced compressor and safety-sealing technologies with ultra-low-GWP R290 refrigerant, delivering around 10% higher energy efficiency. Residential applications include H-Pack and PortaSplit, with PortaSplit set to adopt R290 in 2027.

In the kitchen, technology simplifies daily routines, from food storage and cooking to after-meal care. The Visionary Series refrigerators make food easier to see and access through GlassVision, hands-free lighting and clear, even illumination.

The InfiniteFit Series hobs feature an ultra-slim design for seamless integration into European kitchens, while OmniFlex enables flexible cookware placement. The PizzaPro built-in oven combines rapid heating with an 81L cavity, balancing speed with capacity.

After the meal, the Tri-GreenApex System brings washing, drying and storage together while using around 50% less energy than required for Europe’s highest A rating.

Laundry brings its own everyday needs. Midea’s family laundry room concept combines multi-drum solutions for different garment-care needs, allowing separate loads to run at the same time. The OMNI SERIES offers flexible combinations to suit different household routines.

Tobin Richardson, President and CEO of the Connectivity Standards Alliance, introduced Matter at Midea’s booth, highlighting its open, secure, interoperable framework and Midea’s role in advancing smart appliance connectivity.

Partnership and Brand Portfolio

At IFA 2026, Midea celebrated its partnership through an immersive FC Barcelona experience at its booth. FC Barcelona legend Carles Puyol made a special appearance, sharing insights from his career on leadership, teamwork and the pursuit of excellence. His presence reflected Midea and FC Barcelona’s shared commitment to world-class performance.

As part of Midea Group’s multi-brand portfolio, TEKA presents its latest innovations under the “Meaningful Experiences Through Technology” concept, including its new coffee machine range, the In-Line Series and Laundry Care solutions, bringing European design and functionality to modern living.

About Midea and Midea Group

Midea is one of over 10 brands within the Smart Home Business of Midea Group.

Founded in 1968, Midea Group is a leading global technology company and one of the world’s largest home appliance manufacturers. As a Fortune Global 500 enterprise, it ranked No. 231 in 2026. The Group has streamlined its core operations into seven high-growth business pillars to drive future growth: Smart Home, Industrial Technologies, Building Technologies, KUKA, New Energy, Midea Healthcare, and ANNTO Logistics.

www.midea-group.com

www.midea.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/midea-brings-simply-ideal-to-life-at-ifa-2026-302870435.html

SOURCE Midea Group

Continue Reading

Trending